DEF 14A: Globalstar's 2024 Proxy Statement: Stockholders to Vote on Directors and Accounting Firm

Globalstar's 2024 proxy statement outlines key proposals for the annual meeting, including the election of directors and ratification of the independent accounting firm.

Summary

• Globalstar, Inc. has released its proxy statement for the 2024 Annual Meeting of Stockholders to be held on May 21, 2024.
• Stockholders will vote to elect William A. Hasler and James Monroe III as Class C Directors and to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2024.
• The Board of Directors recommends voting for both proposals.
• The record date for determining stockholders eligible to vote is April 1, 2024.
• As of the record date, there were 1,883,923,816 shares of voting common stock outstanding.
• The company is furnishing proxy materials via the internet, but printed copies are available upon request.
• The Board has four standing committees: Audit, Compensation, Nominating and Governance, and Strategic Review.
• Thermo holds stock representing a majority of Globalstar's voting power, making it a controlled company under NYSE American rules.
• The Board oversees risk management, including information security and cybersecurity.
• The Board also oversees Environmental, Social, and Governance (ESG) and Diversity, Equity, and Inclusion (DEI) matters.
• The Board currently consists of eight members, but will consist of seven members after the 2024 meeting as Mr. Lovett will not stand for re-election.
• Dr. Paul E. Jacobs serves as CEO, and James Monroe III serves as Executive Chairman of the Board.
• The Audit Committee members are Messrs. Hasler, Wolff and Lovett, with Mr. Hasler as Chairman.
• The Compensation Committee members are Messrs. Monroe, Wolff, and Lovett, with Mr. Monroe as Chairman.
• The Nominating and Governance Committee members are Messrs. Cowan and Monroe, with Mr. Monroe as Chairman.
• The Strategic Review Committee members are Messrs. Cowan, Wolff, Taylor and Hasler, with Mr. Wolff as Chairman.
• The company's executive officers are James Monroe III, Dr. Paul E. Jacobs, Rebecca S. Clary, and L. Barbee Ponder IV.
• The compensation program for executive officers includes a conservative base salary and stock or option bonus programs.
• In March 2024, Dr. Jacobs, Ms. Clary, and Mr. Ponder received shares worth $170,000, $145,000, and $100,000, respectively, as part of the annual bonus plan.
• The company has a clawback policy for the recovery of erroneously awarded compensation.
• The proxy statement includes information on director compensation, executive compensation, security ownership, and related person transactions.
• Thermo and its affiliates beneficially own at least 45% of the Company's Common Stock.
• The company has an understanding with Thermo that it will reimburse Thermo for expenses incurred by Messrs. Monroe, Lynch and Taylor and any other Thermo employee in connection with their services to Globalstar.
• The company has a lease agreement with Thermo Covington, LLC for its headquarters office.
• Thermo holds shares of the Company's Series A Preferred Stock with an aggregate liquidation preference of $136.7 million.
• In connection with the license agreement between Globalstar and XCOM Labs, Inc., a portion of the stock consideration was resold by XCOM to certain long-term investors of Globalstar and XCOM, including Thermo, in private resale transactions exempt from registration under the Securities Act.
• In connection with the August 2023 License Agreement, Globalstar issued 60.6 million shares of its common stock, representing a transaction value of approximately $68.7 million, to XCOM.

Sentiment

Score: 7

Explanation: The document is primarily informational, outlining the proposals for the annual meeting and providing details on corporate governance, executive compensation, and related party transactions. The sentiment is neutral to slightly positive, as it reflects standard corporate procedures and disclosures.

Positives

• The Board is committed to promoting diversity at the Board level.
• The company has a clawback policy for the recovery of erroneously awarded compensation.
• The company has an insider trading policy applicable to all directors, officers, employees, contract employees, consultants, and agents.
• The company has an annual bonus plan designed to reward designated key employees' efforts to meet and exceed the company's financial performance goals for the designated calendar year.

Negatives

• Thermo controls a majority of the voting power, which could limit the influence of other shareholders.
• The company is a controlled company for purposes of the NYSE American rules and are not required to have a majority of independent directors on the Board or to comply with the director independence requirements for compensation and nominating/governance committees.
• Mr. Lovett will not stand for re-election at the 2024 meeting of shareholders.

Risks

• The company's reliance on Thermo for financial support and guarantees could pose a risk if Thermo's financial condition deteriorates.
• Related party transactions with Thermo and XCOM Labs could raise concerns about conflicts of interest.
• The company's success depends on its ability to maintain effective internal controls and cybersecurity measures.
• The company's success depends on its ability to meet and exceed the company's financial performance goals for the designated calendar year.

Future Outlook

The Company is currently in the process of identifying and interviewing candidates for the remaining Class B and Class C directorships and does not expect to complete this process before the Annual Meeting.

Management Comments

• James Monroe III, Executive Chairman, invites stockholders to attend the 2024 Annual Meeting.
• Mr. Monroe has informed us that he intends to vote, on behalf of himself and the entities he controls, in favor of both proposals.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors.

Management Changes

Corporate Governance

Related Party Transactions

• Reimbursement to Thermo for expenses incurred by Thermo employees in connection with their services to Globalstar.
• Lease agreement with Thermo Covington, LLC for the company's headquarters office.
• Dividend payments to Thermo for Series A Preferred Stock.
• Thermo's Guaranty with 2023 Funding Agreement.
• License Agreement Stock Consideration with Thermo and XCOM Labs, Inc.
• License Agreement with XCOM Labs, Inc.

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will shape the company's direction.
• Employees are affected by the company's compensation policies and benefit plans.
• The company's performance impacts its customers and suppliers.
• Creditors are affected by the company's financial stability and ability to meet its obligations.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting of Stockholders on May 21, 2024.
• The company will continue to search for candidates for the remaining Class B and Class C directorships.

Key Dates

Keywords

Globalstar, proxy statement, annual meeting, directors, Ernst & Young, Thermo, executive compensation, related party transactions, corporate governance, stockholders